1. Home
  2. BAC vs NVS Comparison

BAC vs NVS Comparison

Compare BAC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of America Corporation

BAC

Bank of America Corporation

HOLD

Current Price

$56.02

Market Cap

380.6B

Sector

Finance

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$153.07

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAC
NVS
Founded
1784
1895
Country
United States
Switzerland
Employees
213000
75267
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.6B
286.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BAC
NVS
Price
$56.02
$153.07
Analyst Decision
Buy
Hold
Analyst Count
20
5
Target Price
$60.34
$144.00
AVG Volume (30 Days)
34.5M
1.5M
Earning Date
04-15-2026
04-28-2026
Dividend Yield
2.12%
2.16%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.11
$2.30
Revenue Next Year
$5.80
$5.27
P/E Ratio
$14.01
$23.13
Revenue Growth
N/A
N/A
52 Week Low
$44.06
$112.34
52 Week High
$57.55
$170.46

Technical Indicators

Market Signals
Indicator
BAC
NVS
Relative Strength Index (RSI) 71.07 58.07
Support Level $51.20 $149.49
Resistance Level $57.21 $157.63
Average True Range (ATR) 1.12 2.03
MACD 0.41 0.56
Stochastic Oscillator 95.52 87.91

Price Performance

Historical Comparison
BAC
NVS

About BAC Bank of America Corporation

Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: